Designed peptides inhibit Mpro in a dose-dependent manner. The assay conditions were 0.15 μM Mpro, 2 μM s01 in 20 mM HEPES, pH 7.5, and 50 mM NaCl.
Peptide | IC50/μM | Hill slope |
---|---|---|
p12 | 5.36 ± 2.17 | 1.25 ± 0.06 |
p13 | 3.11 ± 1.80 | 0.94 ± 0.09 |
p15 | 5.31 ± 1.08 | 1.17 ± 0.16 |
p16 | 3.76 ± 0.51 | 1.19 ± 0.16 |